{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T06:54:49Z","timestamp":1786604089954,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-77781-0","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T04:54:55Z","timestamp":1732078495000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Bladder cancer detection in urine by novel methylation markers"],"prefix":"10.1038","volume":"14","author":[{"given":"Irene J.","family":"Beijert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit M. M.","family":"Wever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anouk E.","family":"Hentschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yara","family":"van den Burgt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C.","family":"Kauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit I.","family":"Lissenberg-Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Jeroen A.","family":"van Moorselaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renske D. M.","family":"Steenbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakko A.","family":"Nieuwenhuijzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,20]]},"reference":[{"issue":"1","key":"77781_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","volume":"81","author":"M Babjuk","year":"2022","unstructured":"Babjuk, M. et al. European association of urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ). Eur. Urol. 81(1), 75\u201394. https:\/\/doi.org\/10.1016\/j.eururo.2021.08.010 (2022).","journal-title":"Eur. Urol."},{"issue":"2","key":"77781_CR2","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.eururo.2014.01.006","volume":"66","author":"RS Svatek","year":"2014","unstructured":"Svatek, R. S. et al. The economics of bladder cancer: costs and considerations of caring for this disease. Eur. Urol. 66(2), 253\u2013262. https:\/\/doi.org\/10.1016\/j.eururo.2014.01.006 (2014).","journal-title":"Eur. Urol."},{"issue":"4","key":"77781_CR3","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1046\/j.1464-4096.2001.01899.x","volume":"89","author":"DM Burke","year":"2002","unstructured":"Burke, D. M., Shackley, D. C. & O\u2019Reilly, P. H. The community-based morbidity of flexible cystoscopy. BJU Int. 89(4), 347\u2013349. https:\/\/doi.org\/10.1046\/j.1464-4096.2001.01899.x (2002).","journal-title":"BJU Int."},{"issue":"5","key":"77781_CR4","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1464-410x.1990.tb14997.x","volume":"66","author":"KR Clark","year":"1990","unstructured":"Clark, K. R. & Higgs, M. J. Urinary infection following out-patient flexible cystoscopy. Br. J. Urol. 66(5), 503\u2013505. https:\/\/doi.org\/10.1111\/j.1464-410x.1990.tb14997.x (1990).","journal-title":"Br. J. Urol."},{"key":"77781_CR5","doi-asserted-by":"publisher","unstructured":"Yafi, F. A., Brimo, F., Steinberg, J., Aprikian, A. G., Tanguay, S. & Kassouf, W. Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer. Urol. Oncol. 33(2), 66 e25\u201331. https:\/\/doi.org\/10.1016\/j.urolonc.2014.06.008 (2015).","DOI":"10.1016\/j.urolonc.2014.06.008"},{"issue":"1","key":"77781_CR6","doi-asserted-by":"publisher","first-page":"51.e21","DOI":"10.1016\/j.urolonc.2013.08.003","volume":"32","author":"MR Abern","year":"2014","unstructured":"Abern, M. R., Owusu, R. & Inman, B. A. Clinical performance and utility of a DNA methylation urine test for bladder cancer. Urol. Oncol. 32(1), 51.e21\u20136. https:\/\/doi.org\/10.1016\/j.urolonc.2013.08.003 (2014).","journal-title":"Urol. Oncol."},{"issue":"12","key":"77781_CR7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s11934-018-0861-5","volume":"19","author":"SP Porten","year":"2018","unstructured":"Porten, S. P. Epigenetic alterations in bladder cancer. Curr. Urol. Rep. 19(12), 102. https:\/\/doi.org\/10.1007\/s11934-018-0861-5 (2018).","journal-title":"Curr. Urol. Rep."},{"issue":"11","key":"77781_CR8","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.tig.2021.05.002","volume":"37","author":"A Nishiyama","year":"2021","unstructured":"Nishiyama, A. & Nakanishi, M. Navigating the DNA methylation landscape of cancer. Trends Genet. 37(11), 1012\u20131027. https:\/\/doi.org\/10.1016\/j.tig.2021.05.002 (2021).","journal-title":"Trends Genet."},{"issue":"8","key":"77781_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0200906","volume":"13","author":"J Bosschieter","year":"2018","unstructured":"Bosschieter, J. et al. A protocol for urine collection and storage prior to DNA methylation analysis. PLoS One 13(8), e0200906. https:\/\/doi.org\/10.1371\/journal.pone.0200906 (2018).","journal-title":"PLoS One"},{"key":"77781_CR10","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.lungcan.2022.06.013","volume":"170","author":"BMM Wever","year":"2022","unstructured":"Wever, B. M. M. et al. Detection of non-metastatic non-small-cell lung cancer in urine by methylation-specific PCR analysis: A feasibility study. Lung Cancer 170, 156\u2013164. https:\/\/doi.org\/10.1016\/j.lungcan.2022.06.013 (2022).","journal-title":"Lung Cancer"},{"issue":"2","key":"77781_CR11","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/ijc.34504","volume":"153","author":"BMM Wever","year":"2023","unstructured":"Wever, B. M. M. et al. DNA methylation testing for endometrial cancer detection in urine, cervicovaginal self-samples and cervical scrapes. Int. J. Cancer 153(2), 341\u2013351. https:\/\/doi.org\/10.1002\/ijc.34504 (2023).","journal-title":"Int. J. Cancer"},{"issue":"10","key":"77781_CR12","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1002\/ijc.33459","volume":"148","author":"NB Thuijs","year":"2021","unstructured":"Thuijs, N. B. et al. DNA methylation markers for cancer risk prediction of vulvar intraepithelial neoplasia. Int. J. Cancer 148(10), 2481\u20132488. https:\/\/doi.org\/10.1002\/ijc.33459 (2021).","journal-title":"Int. J. Cancer"},{"issue":"W1","key":"77781_CR13","doi-asserted-by":"publisher","first-page":"W561","DOI":"10.1093\/nar\/gkz445","volume":"47","author":"A Koch","year":"2019","unstructured":"Koch, A., Jeschke, J., Van Criekinge, W., van Engeland, M. & De Meyer, T. MEXPRESS update 2019. Nucleic Acids Res. 47(W1), W561\u2013W565. https:\/\/doi.org\/10.1093\/nar\/gkz445 (2019).","journal-title":"Nucleic Acids Res."},{"key":"77781_CR14","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1186\/1471-2407-12-551","volume":"12","author":"S Snellenberg","year":"2012","unstructured":"Snellenberg, S. et al. Development of a multiplex methylation-specific PCR as candidate triage test for women with an HPV-positive cervical scrape. BMC Cancer 12, 551. https:\/\/doi.org\/10.1186\/1471-2407-12-551 (2012).","journal-title":"BMC Cancer"},{"issue":"6","key":"77781_CR15","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3(6), 1101\u20131108. https:\/\/doi.org\/10.1038\/nprot.2008.73 (2008).","journal-title":"Nat. Protoc."},{"issue":"6","key":"77781_CR16","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989x06295361","volume":"26","author":"AJ Vickers","year":"2006","unstructured":"Vickers, A. J. & Elkin, E. B. Decision curve analysis: a novel method for evaluating prediction models. Med. Decis. Making 26(6), 565\u2013574. https:\/\/doi.org\/10.1177\/0272989x06295361 (2006).","journal-title":"Med. Decis. Making"},{"key":"77781_CR17","doi-asserted-by":"publisher","unstructured":"van Kessel, K. E. M., de Jong, J. J., Ziel-van der Made, A. C. J. et al. A urine based genomic assay to triage patients with hematuria for cystoscopy. J. Urol. 204(1), 50\u201357. https:\/\/doi.org\/10.1097\/ju.0000000000000786 (2020).","DOI":"10.1097\/ju.0000000000000786"},{"key":"77781_CR18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.urology.2019.01.011","volume":"126","author":"AN Gonzalez","year":"2019","unstructured":"Gonzalez, A. N. et al. The prevalence of bladder cancer during cystoscopy for asymptomatic microscopic hematuria. Urology 126, 34\u201338. https:\/\/doi.org\/10.1016\/j.urology.2019.01.011 (2019).","journal-title":"Urology"},{"issue":"5","key":"77781_CR19","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/j.juro.2010.12.093","volume":"185","author":"H Jung","year":"2011","unstructured":"Jung, H. et al. Association of hematuria on microscopic urinalysis and risk of urinary tract cancer. J. Urol. 185(5), 1698\u20131703. https:\/\/doi.org\/10.1016\/j.juro.2010.12.093 (2011).","journal-title":"J. Urol."},{"issue":"1","key":"77781_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.eururo.2018.03.008","volume":"74","author":"WS Tan","year":"2018","unstructured":"Tan, W. S. et al. Who should be investigated for haematuria? Results of a contemporary prospective observational study of 3556 patients. Eur. Urol. 74(1), 10\u201314. https:\/\/doi.org\/10.1016\/j.eururo.2018.03.008 (2018).","journal-title":"Eur. Urol."},{"issue":"18","key":"77781_CR21","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1001\/jama.1990.03440180081037","volume":"263","author":"JM Sutton","year":"1990","unstructured":"Sutton, J. M. Evaluation of hematuria in adults. JAMA 263(18), 2475\u20132480 (1990).","journal-title":"JAMA"},{"issue":"6","key":"77781_CR22","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nrurol.2013.89","volume":"10","author":"R Kandimalla","year":"2013","unstructured":"Kandimalla, R., van Tilborg, A. A. & Zwarthoff, E. C. DNA methylation-based biomarkers in bladder cancer. Nat. Rev. Urol. 10(6), 327\u2013335. https:\/\/doi.org\/10.1038\/nrurol.2013.89 (2013).","journal-title":"Nat. Rev. Urol."},{"key":"77781_CR23","doi-asserted-by":"publisher","unstructured":"Zhang, J., Xu, R., Lu, Q. et al. A novel methylation marker NRN1 plus TERT and FGFR3 mutation using urine sediment enables the detection of urothelial bladder carcinoma. Cancers (Basel) 15(3). https:\/\/doi.org\/10.3390\/cancers15030615 (2023).","DOI":"10.3390\/cancers15030615"},{"key":"77781_CR24","doi-asserted-by":"publisher","first-page":"7272960","DOI":"10.1155\/2020\/7272960","volume":"2020","author":"XH Ning","year":"2020","unstructured":"Ning, X. H. et al. A three protein-coding gene prognostic model predicts overall survival in bladder cancer patients. Biomed. Res. Int. 2020, 7272960. https:\/\/doi.org\/10.1155\/2020\/7272960 (2020).","journal-title":"Biomed. Res. Int."},{"issue":"3 Pt 1","key":"77781_CR25","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.juro.2016.09.118","volume":"197","author":"KE van Kessel","year":"2017","unstructured":"van Kessel, K. E. et al. Validation of a DNA methylation-mutation urine assay to select patients with hematuria for cystoscopy. J. Urol. 197(3 Pt 1), 590\u2013595. https:\/\/doi.org\/10.1016\/j.juro.2016.09.118 (2017).","journal-title":"J. Urol."},{"issue":"1","key":"77781_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13148-021-01073-x","volume":"13","author":"W Ruan","year":"2021","unstructured":"Ruan, W. et al. A urine-based DNA methylation assay to facilitate early detection and risk stratification of bladder cancer. Clin. Epigenet. 13(1), 91. https:\/\/doi.org\/10.1186\/s13148-021-01073-x (2021).","journal-title":"Clin. Epigenet."},{"issue":"1","key":"77781_CR27","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13148-021-01029-1","volume":"13","author":"P Piatti","year":"2021","unstructured":"Piatti, P. et al. Clinical evaluation of Bladder CARE, a new epigenetic test for bladder cancer detection in urine samples. Clin. Epigenet. 13(1), 84. https:\/\/doi.org\/10.1186\/s13148-021-01029-1 (2021).","journal-title":"Clin. Epigenet."},{"issue":"3","key":"77781_CR28","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2217\/epi-2018-0094","volume":"11","author":"J Bosschieter","year":"2019","unstructured":"Bosschieter, J. et al. A two-gene methylation signature for the diagnosis of bladder cancer in urine. Epigenomics 11(3), 337\u2013347. https:\/\/doi.org\/10.2217\/epi-2018-0094 (2019).","journal-title":"Epigenomics"},{"issue":"1","key":"77781_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13148-022-01240-8","volume":"14","author":"AE Hentschel","year":"2022","unstructured":"Hentschel, A. E. et al. Bladder cancer detection in urine using DNA methylation markers: a technical and prospective preclinical validation. Clin. Epigenet. 14(1), 19. https:\/\/doi.org\/10.1186\/s13148-022-01240-8 (2022).","journal-title":"Clin. Epigenet."},{"issue":"4","key":"77781_CR30","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.euo.2018.06.011","volume":"1","author":"JA Witjes","year":"2018","unstructured":"Witjes, J. A. et al. Performance of the bladder EpiCheck\u2122 methylation test for patients under surveillance for non-muscle-invasive bladder cancer: results of a multicenter, prospective, blinded clinical trial. Eur. Urol. Oncol. 1(4), 307\u2013313. https:\/\/doi.org\/10.1016\/j.euo.2018.06.011 (2018).","journal-title":"Eur. Urol. Oncol."},{"issue":"6","key":"77781_CR31","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1111\/bju.14673","volume":"123","author":"D D'Andrea","year":"2019","unstructured":"D\u2019Andrea, D. et al. Diagnostic accuracy, clinical utility and influence on decision-making of a methylation urine biomarker test in the surveillance of non-muscle-invasive bladder cancer. BJU Int. 123(6), 959\u2013967. https:\/\/doi.org\/10.1111\/bju.14673 (2019).","journal-title":"BJU Int."},{"issue":"7","key":"77781_CR32","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/cncy.22152","volume":"127","author":"E Trenti","year":"2019","unstructured":"Trenti, E. et al. Diagnostic predictive value of the Bladder EpiCheck test in the follow-up of patients with non-muscle-invasive bladder cancer. Cancer Cytopathol. 127(7), 465\u2013469. https:\/\/doi.org\/10.1002\/cncy.22152 (2019).","journal-title":"Cancer Cytopathol."},{"issue":"4","key":"77781_CR33","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.eururo.2012.05.063","volume":"62","author":"F Liedberg","year":"2012","unstructured":"Liedberg, F. et al. The importance of being grade 3: WHO 1999 versus WHO 2004 pathologic grading. Eur. Urol. 62(4), 620\u2013623. https:\/\/doi.org\/10.1016\/j.eururo.2012.05.063 (2012).","journal-title":"Eur. Urol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77781-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77781-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77781-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T08:24:36Z","timestamp":1732091076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77781-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,20]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["77781"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-77781-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,20]]},"assertion":[{"value":"17 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Renske D. M. Steenbergen holds a minority stake in Self-screen B.V., a spin-off company of Amsterdam UMC, location VUmc, which owns patents and products related to the development of methylation markers for cervical screening. All other authors do not have any competing interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. The study protocol was approved by the Medical Ethics Committee (2018.355 [16-10-2018], WO 18.155 [21-12-2018]) and all participants provided informed written consent before inclusion in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"28705"}}